查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1760847

全球脑瘤诊断与治疗市场

Brain Tumor Diagnosis and Treatment
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 173 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到2030年，全球脑瘤诊断和治疗市场规模将达20亿美元

全球脑瘤诊断和治疗市场规模预计在2024年为16亿美元，预计到2030年将达到20亿美元，2024年至2030年的复合年增长率为4.4%。报告分析的细分市场之一—原发性脑肿瘤，预计其复合年增长率为4.1%，到分析期结束时规模将达到13亿美元。次发性脑肿瘤细分市场在分析期间的复合年增长率估计为4.8%。

美国市场规模估计为 4.105 亿美元，中国市场预计复合年增长率为 7.7%

美国脑肿瘤诊断和治疗市场规模预计在2024年达到4.105亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到4.551亿美元，在2024-2030年的分析期内，复合年增长率为7.7%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.7%和4.6%。在欧洲，预计德国市场的复合年增长率为1.7%。

全球脑肿瘤诊断与治疗市场—主要趋势与驱动因素摘要

脑肿瘤诊疗市场如何发展？

由于影像技术的进步和标靶治疗的发展，脑肿瘤诊断和治疗市场正在快速发展。早期诊断对于有效治疗至关重要，MRI、 电脑断层扫描和 PET 扫描等技术创新提高了检测准确性并缩短了诊断时间。在治疗方面，人们已经从手术和放射等传统方法转向标靶药物治疗和免疫疗法等更先进的治疗手段，这些手段可以更精准地靶向癌细胞，同时最大限度地减少对周围健康组织的损害。

科技在推进脑瘤治疗方面发挥什么作用？

透过人工智慧诊断工具、立体定位放射放射线手术和个人化医疗等创新技术，科技正在推动脑肿瘤治疗的变革。人工智慧演算法透过比传统方法更精确地分析医疗图像，提高了肿瘤检测和表征的准确性。伽玛刀和射电脑刀等立体定位放射线手术能够实现非侵入性、高精度的放射治疗，在靶向肿瘤的同时最大限度地减少对健康组织的影响。包括基因分析在内的个人化治疗方法正在推动开发针对个别患者的标靶治疗。

市场动态与患者人口统计如何影响脑肿瘤治疗？

市场动态和患者人口结构显着影响脑肿瘤的治疗，以患者为中心的个人化治疗方案日益受到重视。脑肿瘤发生率的上升，尤其是在人口老化背景下，推动了对更有效、微创的诊断和治疗方案的需求。此外，人们对脑部健康的认识不断提高，神经肿瘤学的进步也促进了早期诊断和多学科治疗方案的发展。地区间在获得先进医疗服务方面的差异也影响着市场的成长，但北美和欧洲凭藉其完善的医疗基础设施和研究设施，在市场中处于领先地位。

推动脑肿瘤诊疗市场成长的因素有哪些？

脑肿瘤诊断和治疗市场的成长受到多种因素的推动，例如成像技术的进步、标靶治疗和免疫疗法的发展以及全球脑肿瘤发生率的上升。人工智慧和机器学习在诊断领域的应用正在提高检测率和准确性。对非侵入性治疗方案和个人化医疗的需求不断增长，推动着市场走向创新方法。此外，医疗保健支出的增加、意识提升的提高以及政府对癌症研究的资助也促进了市场的扩张。

部分

肿瘤类型（原发性脑瘤、续发性脑肿瘤）、诊断类型（电脑断层扫描、MRI、PET- 电脑断层扫描、腰椎穿刺、脑电图、组织采样、其他诊断类型）、治疗类型（手术、放射线治疗、标靶治疗、化疗治疗、免疫治疗、其他治疗类型）

受访公司范例（总合42家公司）

  • AstraZeneca PLC
  • Carestream Health, Inc.
  • GE Healthcare
  • Hitachi Medical Corporation
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • Shimadzu Corporation
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP15763

Global Brain Tumor Diagnosis and Treatment Market to Reach US$2.0 Billion by 2030

The global market for Brain Tumor Diagnosis and Treatment estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Primary Brain Tumor, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Secondary Brain Tumor segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$410.5 Million While China is Forecast to Grow at 7.7% CAGR

The Brain Tumor Diagnosis and Treatment market in the U.S. is estimated at US$410.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$455.1 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Brain Tumor Diagnosis and Treatment Market - Key Trends & Drivers Summarized

How Is the Brain Tumor Diagnosis and Treatment Market Evolving?

The brain tumor diagnosis and treatment market is evolving rapidly due to advancements in imaging technologies and the development of targeted therapies. Early diagnosis is critical for effective treatment, and innovations such as MRI, CT scans, and PET scans are enhancing detection accuracy and reducing diagnostic times. In terms of treatment, there is a shift from traditional methods like surgery and radiation to more advanced options such as targeted drug therapy and immunotherapy, which offer better precision in targeting tumor cells while minimizing damage to surrounding healthy tissues.

What Role Does Technology Play in Advancing Brain Tumor Treatment?

Technology is playing a transformative role in advancing brain tumor treatment through innovations like AI-powered diagnostic tools, stereotactic radiosurgery, and personalized medicine. AI algorithms are improving the accuracy of tumor detection and characterization by analyzing medical imaging with greater precision than conventional methods. Stereotactic radiosurgery, such as Gamma Knife and CyberKnife, allows for non-invasive, high-precision radiation treatment that targets tumors with minimal impact on healthy tissues. Personalized treatment approaches, including genetic profiling, are enabling the development of targeted therapies tailored to individual patient profiles.

How Are Market Dynamics and Patient Demographics Shaping Brain Tumor Care?

Market dynamics and patient demographics are significantly shaping brain tumor care, with an increasing emphasis on patient-centered and personalized treatment approaches. The rising incidence of brain tumors, particularly among aging populations, is driving demand for more effective and less invasive diagnostic and therapeutic options. Additionally, the growing awareness of brain health and advancements in neuro-oncology are encouraging early diagnosis and multidisciplinary treatment plans. Regional disparities in access to advanced care are also influencing market growth, with North America and Europe leading due to well-established healthcare infrastructure and research facilities.

What Factors Are Driving the Growth in the Brain Tumor Diagnosis and Treatment Market?

The growth in the brain tumor diagnosis and treatment market is driven by several factors, including advancements in imaging technologies, the development of targeted and immunotherapies, and the increasing incidence of brain tumors globally. The integration of AI and machine learning in diagnostics is improving detection rates and accuracy. The rising demand for non-invasive treatment options and personalized medicine is pushing the market towards innovative approaches. Furthermore, increasing healthcare expenditure, awareness, and government funding for cancer research are also contributing to the market's expansion.

SCOPE OF STUDY:

The report analyzes the Brain Tumor Diagnosis and Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Tumor Type (Primary Brain Tumor, Secondary Brain Tumor); Diagnosis Type (CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling, Other Diagnosis Types); Treatment Type (Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy, Other Treatment Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AstraZeneca PLC
  • Carestream Health, Inc.
  • GE Healthcare
  • Hitachi Medical Corporation
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • Shimadzu Corporation
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Brain Tumor Diagnosis and Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Brain Tumors Driving Demand for Diagnostic and Treatment Solutions
    • Technological Advancements in MRI and CT Imaging for Early Tumor Detection
    • Growth in Targeted Therapy and Immunotherapy Applications for Brain Tumor Treatment
    • Increasing Adoption of AI and Machine Learning for Accurate Tumor Diagnosis
    • Expansion of Minimally Invasive Surgical Techniques in Brain Tumor Removal
    • Impact of Personalized Medicine and Genomic Studies on Treatment Strategies
    • Rising Investments in Research for Developing Advanced Diagnostic Tools
    • Growing Use of Radiotherapy and Radiosurgery in Brain Tumor Management
    • Development of Innovative Drug Delivery Systems for Brain Tumor Treatment
    • Emergence of Liquid Biopsy Techniques for Non-Invasive Diagnosis
    • Increasing Focus on Clinical Trials and Approvals for Novel Therapeutics
    • Impact of Healthcare Infrastructure Development in Emerging Markets on Accessibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Brain Tumor Diagnosis and Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Primary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Primary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Primary Brain Tumor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Secondary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Secondary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Secondary Brain Tumor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for CT Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for PET-CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for PET-CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for PET-CT Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Lumbar Puncture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Lumbar Puncture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Lumbar Puncture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for EEG by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for EEG by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for EEG by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Tissue Sampling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Tissue Sampling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Tissue Sampling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Diagnosis Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Targeted Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • CHINA
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 131: UK Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Spain 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 140: Spain Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Spain Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Spain 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Russia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 149: Russia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Russia Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Russia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 176: Australia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Australia Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Australia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 179: Australia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Australia Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Australia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • INDIA
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 182: India Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 185: India Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: India Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: India 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 188: India Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: India Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: India 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 194: South Korea Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: South Korea Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: South Korea 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 197: South Korea Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: South Korea Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: South Korea 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 215: Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 218: Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 224: Argentina Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Argentina Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Argentina 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 227: Argentina Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Argentina Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Argentina 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 233: Brazil Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Brazil Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Brazil 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 236: Brazil Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Brazil Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Brazil 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 242: Mexico Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Mexico Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Mexico 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 245: Mexico Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Mexico Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Mexico 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 254: Rest of Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Rest of Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 263: Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 266: Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 272: Iran Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Iran Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Iran 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 275: Iran Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Iran Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Iran 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 281: Israel Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Israel Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Israel 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 284: Israel Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Israel Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Israel 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Saudi Arabia Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Saudi Arabia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 293: Saudi Arabia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Saudi Arabia Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Saudi Arabia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 299: UAE Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: UAE Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: UAE 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 302: UAE Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: UAE Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: UAE 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 317: Africa Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Africa Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Africa 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 320: Africa Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Africa Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Africa 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030

IV. COMPETITION